Association of antibiotic exposure with Kawasaki disease
Abstract
Kawasaki disease (KD) is an acute febrile vasculitis of unknown etiology that primarily affects children under five years old. Emerging evidence suggests that gut microbiota alterations may contribute to KD pathogenesis. Because antibiotics modify intestinal microbial composition, their inappropriate or repeated use in early childhood may increase KD susceptibility. However, population-based evidence linking antibiotic exposure with KD onset remains limited, and the influence of antibiotic class, number of antibiotic prescriptions, and administration route has not been systematically evaluated. To examine the association between antibiotic type, number of antibiotic prescriptions, route of administration, and KD onset in a nationwide dataset. We conducted a matched case–control study using the JMDC database (2005–2024). Children aged 0–6 years were eligible. Newly diagnosed KD cases ( n = 17,410) and controls ( n = 68,621) were matched 1:4 by age, sex, and birth year. Antibiotic exposure from birth until one month before the index date was assessed by class (penicillins, cephalosporins, macrolides, quinolones, others), number of antibiotic prescriptions, and administration route (oral vs. intravenous). Multivariable conditional logistic regression estimated odds of KD onset adjusted for antiviral agent use, antifungal agent use, preterm birth, and low birth weight, with matching by age, sex, and birth year accounted for in the conditional analysis. Among 86,031 children, exposure to penicillins (OR, 1.27; 95% CI, 1.21–1.34), cephalosporins (OR, 1.16; 95% CI, 1.10–1.23), quinolones (OR, 1.48; 95% CI, 1.27–1.73), and macrolides (OR, 1.19; 95% CI, 1.09–1.31) was associated with increased KD risk. Higher odds of KD were observed with increasing numbers of antibiotic prescriptions (≥ 5 prescriptions: OR, 1.22; 95% CI, 1.16–1.28). Oral antibiotic use showed a significant association (OR, 1.22; 95% CI, 1.16–1.27), while intravenous use did not. Repeated antibiotic prescriptions, especially via oral administration, were associated with KD. These findings support an association between prior antibiotic exposure and KD, warranting further mechanistic investigation.
Related
- Association of granulocyte colony-stimulating factor and immature neutrophils with treatment resistance in Kawasaki disease
- Meteorological and airborne pollution exposure that potentially affects the incidence of Kawasaki disease.
- Association between antibiotic exposure and survival outcomes in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
- Application of AI-assisted compressed sensing cine sequence in the assessment of cardiac function in children with Kawasaki disease
- Temporal drift, calibration monitoring, and adaptive updating of an IVIG resistance prediction model in Kawasaki disease: a multicenter pediatric cohort study
BibTeX
@article{suzuki2026association,
title = {{Association of antibiotic exposure with Kawasaki disease}},
author = {Takanori Suzuki and Jumpei Yoshida and Nobuaki Michihata and Kazuyoshi Saito and Hidetoshi Uchida and Arisa Kojima and Yumiko Asai and Tadayoshi Hata and Tetsushi Yoshikawa},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74617-x},
url = {https://www.nature.com/articles/s41598-026-74617-x},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Association of antibiotic exposure with Kawasaki disease
AU - Takanori Suzuki
AU - Jumpei Yoshida
AU - Nobuaki Michihata
AU - Kazuyoshi Saito
AU - Hidetoshi Uchida
AU - Arisa Kojima
AU - Yumiko Asai
AU - Tadayoshi Hata
AU - Tetsushi Yoshikawa
PY - 2026
DA - 2026/10/28
JO - Scientific Reports
DO - 10.1038/s41598-026-74617-x
UR - https://www.nature.com/articles/s41598-026-74617-x
AB - Kawasaki disease (KD) is an acute febrile vasculitis of unknown etiology that primarily affects children under five years old. Emerging evidence suggests that gut microbiota alterations may contribute to KD pathogenesis. Because antibiotics modify intestinal microbial composition, their inappropriate or repeated use in early childhood may increase KD susceptibility. However, population-based evidence linking antibiotic exposure with KD onset remains limited, and the influence of antibiotic class, number of antibiotic prescriptions, and administration route has not been systematically evaluated. To examine the association between antibiotic type, number of antibiotic prescriptions, route of administration, and KD onset in a nationwide dataset. We conducted a matched case–control study using the JMDC database (2005–2024). Children aged 0–6 years were eligible. Newly diagnosed KD cases ( n = 17,410) and controls ( n = 68,621) were matched 1:4 by age, sex, and birth year. Antibiotic exposure from birth until one month before the index date was assessed by class (penicillins, cephalosporins, macrolides, quinolones, others), number of antibiotic prescriptions, and administration route (oral vs. intravenous). Multivariable conditional logistic regression estimated odds of KD onset adjusted for antiviral agent use, antifungal agent use, preterm birth, and low birth weight, with matching by age, sex, and birth year accounted for in the conditional analysis. Among 86,031 children, exposure to penicillins (OR, 1.27; 95% CI, 1.21–1.34), cephalosporins (OR, 1.16; 95% CI, 1.10–1.23), quinolones (OR, 1.48; 95% CI, 1.27–1.73), and macrolides (OR, 1.19; 95% CI, 1.09–1.31) was associated with increased KD risk. Higher odds of KD were observed with increasing numbers of antibiotic prescriptions (≥ 5 prescriptions: OR, 1.22; 95% CI, 1.16–1.28). Oral antibiotic use showed a significant association (OR, 1.22; 95% CI, 1.16–1.27), while intravenous use did not. Repeated antibiotic prescriptions, especially via oral administration, were associated with KD. These findings support an association between prior antibiotic exposure and KD, warranting further mechanistic investigation.
SN - 2045-2322
ER -